Free Trial

McKesson (MCK) Stock Forecast & Price Target

McKesson logo
$711.32 -8.48 (-1.18%)
Closing price 09/12/2025 03:59 PM Eastern
Extended Trading
$714.50 +3.18 (+0.45%)
As of 09/12/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

McKesson - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
3
Buy
10

Based on 13 Wall Street analysts who have issued ratings for McKesson in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 13 analysts, 3 have given a hold rating, 9 have given a buy rating, and 1 has given a strong buy rating for MCK.

Consensus Price Target

$725.10
1.94% Upside
According to the 13 analysts' twelve-month price targets for McKesson, the average price target is $725.10. The highest price target for MCK is $810.00, while the lowest price target for MCK is $579.00. The average price target represents a forecasted upside of 1.94% from the current price of $711.32.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for MCK and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for McKesson and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MCK Analyst Ratings Over Time

TypeCurrent Forecast
9/13/24 to 9/13/25
1 Month Ago
8/14/24 to 8/14/25
3 Months Ago
6/15/24 to 6/15/25
1 Year Ago
9/14/23 to 9/13/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
9 Buy rating(s)
10 Buy rating(s)
11 Buy rating(s)
13 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$725.10$719.27$694.38$620.93
Forecasted Upside1.94% Upside6.63% Upside-4.51% Downside19.68% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

MCK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MCK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

McKesson Stock vs. The Competition

TypeMcKessonMedical CompaniesS&P 500
Consensus Rating Score
2.85
2.78
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside1.94% Upside17,449.72% Upside10.72% Upside
News Sentiment Rating
Positive News

See Recent MCK News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
8/13/2025Wells Fargo & Company
3 of 5 stars
Stephen Baxter
Stephen Baxter
4 of 5 stars
Boost TargetEqual Weight$766.00 ➝ $772.00+17.19%
8/7/2025Cowen
1 of 5 stars
 Reiterated RatingBuy
7/16/2025Morgan Stanley
3 of 5 stars
Erin Wright
Erin Wright
5 of 5 stars
Reiterated RatingOverweight$770.00 ➝ $810.00+13.92%
7/9/2025Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$760.00 ➝ $800.00+10.52%
5/9/2025Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$755.00 ➝ $800.00+15.11%
4/29/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$708.00 ➝ $805.00+14.56%
4/4/2025Cfra Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeModerate BuyHold
4/3/2025Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetNeutral$630.00 ➝ $690.00-3.81%
1/10/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetBuy$713.00 ➝ $677.00+15.15%
11/7/2024Baird R W
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldStrong-Buy
11/7/2024Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 UpgradeNeutralOutperform$531.00 ➝ $688.00+25.25%
10/7/2024Leerink Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetOutperform$665.00 ➝ $630.00+29.78%
9/25/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetBuy$623.00 ➝ $579.00+20.99%
8/21/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOverweight$656.00 ➝ $661.00+19.54%
8/8/2024Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOverweight$596.00 ➝ $616.00+12.78%
6/24/2024Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$570.00 ➝ $670.00+11.10%
5/8/2024TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$563.00 ➝ $652.00+19.74%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 11:29 AM ET.


Should I Buy McKesson Stock? MCK Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, September 9, 2025. Please send any questions or comments about these McKesson pros and cons to contact@marketbeat.com.

McKesson
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in McKesson Co.:

  • McKesson Co. has received multiple positive ratings from analysts, with one analyst giving it a "Strong Buy" rating and several others issuing "Buy" ratings, indicating strong market confidence in the company's future performance.
  • The current stock price is around $687, which is significantly higher than its 1-year low of approximately $464, suggesting a strong recovery and potential for further growth.
  • Recent price target increases from analysts, such as Evercore ISI raising their target to $800, reflect optimism about the company's financial health and growth prospects.
  • McKesson Co. operates in a critical sector, providing healthcare services, which tends to be more resilient during economic downturns, making it a potentially safer investment.
  • The company has a solid market capitalization of over $85 billion, indicating a strong position in the market and the ability to invest in growth opportunities.

McKesson
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in McKesson Co. for these reasons:

  • Insider selling has been observed, with significant shares sold by the CEO and other executives, which may raise concerns about their confidence in the company's future performance.
  • The stock has shown volatility, with a beta of 0.51, indicating that it may not be as stable as some investors prefer, especially in uncertain market conditions.
  • Despite positive ratings, the average target price from analysts is around $725.10, which is only slightly above the current stock price, suggesting limited upside potential in the near term.
  • McKesson Co. operates in a highly competitive industry, which could impact its market share and profitability if competitors gain an advantage.
  • The company's P/E ratio of 27.39 indicates that it may be overvalued compared to its earnings, which could deter value-focused investors.

MCK Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for McKesson is $725.10, with a high forecast of $810.00 and a low forecast of $579.00.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last twelve months. There are currently 3 hold ratings, 9 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" MCK shares.

According to analysts, McKesson's stock has a predicted upside of 1.94% based on their 12-month stock forecasts.

McKesson has been rated by research analysts at Cowen, Evercore ISI, Morgan Stanley, and Wells Fargo & Company in the past 90 days.

Analysts like McKesson more than other "medical" companies. The consensus rating score for McKesson is 2.85 while the average consensus rating score for "medical" companies is 2.78. Learn more on how MCK compares to other companies.


This page (NYSE:MCK) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners